Navigation Links
HerbalScience Research Identifies Specific Bioactives In Stabilized Rice Bran Extract that Impart Anti-Inflammatory Benefits
Date:8/12/2009

NEW YORK, Aug. 12 /PRNewswire/ -- Rice bran, a by-product of rice milling, is known to be an excellent source of antioxidants, vitamins, and other critical nutrients. What's more, stabilized rice bran - created via new methods of processing that stabilizes the bran and extends its life and nutritional value - has been shown in studies to play a role in treating diabetes and arthritis, although its exact mode-of-action was unknown. Now, the specific bioactive compounds that impart the anti-inflammatory health benefits of stabilized rice bran have been identified in research conducted by scientists at HerbalScience Group, LLC - opening the door to the development of functional foods and dietary supplements to help control inflammation and promote joint health.

An article detailing the study, titled "Pro-Inflammatory Enzymes, Cyclooxygenase 1, Cyclooxygenase 2, and 5-Lipooxygenase, Inhibited by Stabilized Rice Bran Extracts," has been published in the June 2009 issue of the peer-review Journal of Medicinal Food. The authors of the article are all affiliated with HerbalScience Group, a Naples, Florida, and Singapore-based company dedicated to applying advanced science and technology to the production of botanical drugs and nutraceuticals.

"Arthritis is already the most common form of disability in the United States, and is expected to afflict some 59 million people by the year 2020," said Randall S. Alberte, Ph.D., Chief Scientific Officer of HerbalScience Group and one of the authors of the published study. "The inflammation of the joints that occurs in arthritis is a direct result of the production of specific pro-inflammatory enzymes at the site that generate inflammation mediators. So identifying the key bioactive compounds in stabilized rice bran extract that inhibit those enzymes is the first step toward developing safe and effective natural treatments for arthritis and a range of other inflammatory diseases."

In the laboratory research, two different stabilized rice bran extracts were created through a proprietary extraction technology developed by HerbalScience. The extraction procedures, which included supercritical CO2 and affinity absorbent technologies for extracting plant phytochemicals, enabled the company to standardize the chemical profile of any selected botanical in order to deliver a product that is compositionally and functionally consistent batch to batch. The study also included a third extract that was created as a combination of the original two extracts in a 1:6 ratio.

Each of the extracts was tested for its ability to inhibit the key pro-inflammatory enzymes - cyclooxygenase 1 [COX1], cyclooxygenase 2 [COX2], and 5-lipooxygenase [5-LOX] - that are known contributors to impaired joint health, pain, and arthritis. All three extracts demonstrated enzyme inhibition, with the highest level of inhibition of all three enzymes achieved with the extract blend.

In addition, the study identified specific bioactive compounds in each of the extracts as being likely significant contributors to the COX and/or 5-LOX inhibition activities. While a few were already known for anti-inflammatory characteristics, the anti-inflammatory activity of several other compounds had not been reported by any previous research. This analysis of the individual chemical constituents in the extracts was enabled through use of a DART (Direct Analysis in Real Time) Time-of-Flight mass spectrometer, one of the most advanced mass spectrometric technologies available. The DART-TOF is able to detect, identify with high accuracy, and quantify the hundreds or thousands of individual chemicals present in botanical extracts.

"Botanical extracts have a long history of use for arthritis and inflammatory diseases, but now, through our research and technologies developed at HerbalScience, we are able to identify the specific chemical compounds in the botanicals that offer health benefits," said Dr. Alberte. "From the results of this study, it is clear that these stabilized rice bran extracts hold great promise for natural, safe, and effective treatments of arthritis in the form of dietary supplements or functional foods."

The article describing the rice bran study is in the June 2009, Volume 12, Number 3, issue of Journal of Medicinal Food as: "Pro-Inflammatory Enzymes, Cyclooxygenase 1, Cyclooxygenase 2, and 5-Lipooxygenase, Inhibited by Stabilized Rice Bran Extracts," DOI: 10.1089/jmf.2008.0133, authored by Bill Roschek, Jr., Ryan C. Fink, Dan Li, Matthew McMichael, Christine M. Tower, Robert D. Smith, and Randall S. Alberte, all of HerbalScience Group LLC.

HerbalScience Group LLC is a privately-held life sciences company headquartered in Naples, Florida, with facilities in Singapore. HerbalScience is engaged in the discovery, development, manufacture, and marketing of proprietary botanical compounds for human health in the U.S. and international markets. The company has prominent alliances with prestigious university laboratories and prominent researchers in the U.S., as well as research institutions in China.


'/>"/>
SOURCE HerbalScience
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
2. Stem Cell Advance May Further Disease Research
3. Researchers find alcoholics display abnormal brain activity when processing facial expressions
4. UT Southwestern researchers launch study into search-and-destroy antigen for deadly skin cancer
5. New Research Study May Lead to Personalized Approach to Breast Cancer Screenings
6. Hollins Communications Research Institute Announces More Stuttering Therapy Scholarships
7. Thomson Reuters Research Identifies Top U.S. Health Systems
8. Indiana University research at the American Sociological Association annual meeting
9. Researchers Produce First Nationwide Study of Homeless in ERs
10. U.S. Stem Cell Research Seems to Focus on Two Lines
11. Yerkes researchers propose ambitious new strategies for AIDS vaccine research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... San Francisco, CA (PRWEB) , ... April 29, ... ... recently released fertility clinic data for 2014. Each year, reproductive endocrinologists are required ... CDC and SART, the main organization of professionals dedicated to the practice of ...
(Date:4/29/2016)... Los Angeles, California (PRWEB) , ... April 29, 2016 , ... ... all across USA, 1Heart Caregiver Services continues its successful franchise development and expansion as ... Ferdie has an extensive managerial and administrative experience in his 32 years of working ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ... announced it has signed a letter of intent with Moda to ... Insurance Company (NORDIC). , Started by dentists 36 years ago, TDIC focuses exclusively ...
(Date:4/28/2016)... ... April 28, 2016 , ... CastCoverz!, America’s ... with AquaShieldUSA, the country's oldest waterproof cast protector . As the largest ... the largest selection of daily, night, weatherproof and waterproof covers for most orthopedic ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... was among the organization’s most successful events, attracting medical professionals from around the ... and stimulating networking events. , Opening Ceremonies Sunday, April 17 included the introduction ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 Transparency Market Research ... Market - Global Industry Analysis, Size, Share, Growth, Trends, ... the global skincare devices market was valued at US$ ... at a CAGR of 10.1% from 2015 to 2023 ... Browse the full Skincare Devices Market (Treatment Device - LED ...
(Date:4/27/2016)... 27, 2016  Bayer Animal Health today announced ... the University of Florida College of Veterinary Medicine, ... in Communication Award (BECA). Brittany was selected from ... a total of $70,000 in scholarship funds through ... Bayer has provided a total of $232,500 in ...
(Date:4/27/2016)... , April 27, 2016 ... ), a developer of a new generation of ... positive overall survival results for Paclical/Apealea in the ... 789 patients with epithelial ovarian cancer. These preliminary ... Paclical/Apealea in combination with carboplatin versus Taxol in ...
Breaking Medicine Technology: